Cargando…
Long non-coding RNA HAND2-AS1 downregulation predicts poor survival of patients with end-stage dilated cardiomyopathy
OBJECTIVE: Insulin-like growth factor-1 (IGF-1) signaling is inhibited in end-stage dilated cardiomyopathy (DCM), and recombinant IGF-1 improves cardiac function in DCM patients. Long non-coding (lnc)RNA HAND2-AS1 was previously shown to be involved in cancer development, but its role in DCM is unkn...
Autores principales: | Cheng, Xianlu, Jiang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726814/ https://www.ncbi.nlm.nih.gov/pubmed/31248315 http://dx.doi.org/10.1177/0300060519849295 |
Ejemplares similares
-
In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy
por: Liu, Shanshan, et al.
Publicado: (2017) -
Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013) -
Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy
por: Zhu, Xiaoming, et al.
Publicado: (2013) -
Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes
por: Zha, Tianjian, et al.
Publicado: (2019) -
The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy
por: Zhang, Yanlin, et al.
Publicado: (2017)